Home  |  Site Map  |  Glossary  | Contact
Oct. 28

QLT Announces Third Quarter 2014 Results

   
OCT. 24

QLT Appoints Dr. Geoffrey F. Cox as Interim Chief Executive Officer

Announces 2014 Annual General Meeting Date

   
Oct. 9 QLT Announces Merger with Auxilium Pharmaceuticals, Inc. Terminates for Superior Proposal
   
SEPT. 22 QLT Provides Further Update on Merger with Auxilium Pharmaceuticals, Inc.
   
SEPT. 17 QLT Provides Update on Merger with Auxilium Pharmaceuticals, Inc.
   
Sept. 13

Vision Improvement After Retreatment with an Oral Synthetic cis-Retinoid (QLT091001) in Subjects with Inherited Retinal Disease caused by Mutations in RPE65 or LRAT

 
Copyright 2000-2009 QLT Inc. Legal Terms for use of site and Privacy Policy | Disclaimer
Vancouver Web Design by Graphically Speaking
 
Employee Login
 
'ss